• Login
    View Item 
    •   ORKA Home
    • Settings
    • Population Health
    • View Item
    •   ORKA Home
    • Settings
    • Population Health
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Public opinion on global rollout of COVID-19 vaccines

    Thumbnail
    Date
    2021-03
    Author
    External author(s) only
    Metadata
    Show full item record
    Citation
    Clarke, P.M., Roope, L.S.J., Loewen, P.J., Jean-Francois Bonnefon, Alessia Melegaro, Jorge Friedman, Mara Violato, Adrian Barnett & Raymond Duch. Public opinion on global rollout of COVID-19 vaccines. Nat Med 27, 935–936 (2021).
    Abstract
    To the Editor—Vaccination programs for COVID-19 in ‘high-income countries’ (HICs) have benefited from their ability to secure contracts for preferential supply for several vaccines1. For the rest of the world, vaccine access is much less certain. Although leaders of G20 nations have pledged to ensure fair distribution of vaccines against COVID-19 worldwide, substantial challenges remain. The COVAX Facility aims to ensure that all countries will have equal access to doses and can compete with HICs to acquire doses, but some low-income countries may need to wait until at least 2022 before even the most vulnerable 20% of their populations are vaccinated2
    URI
    https://oxfordhealth-nhs.archive.knowledgearc.net/handle/123456789/872
    Published online at:
    https://doi.org/10.1038/s41591-021-01322-9
    Collections
    • Population Health [22]

    Oxford Health copyright © 2019
    Contact Us | Send Feedback | JSPUI
    Powered by KnowledgeArc
     

     

    Browse

    All of ORKACommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsContributor DisciplineThis CollectionBy Issue DateAuthorsTitlesSubjectsContributor Discipline

    My Account

    Login

    Researcher Profiles

    Researchers

    Oxford Health copyright © 2019
    Contact Us | Send Feedback | JSPUI
    Powered by KnowledgeArc